ThermaGenix was founded in 2016 by Professor Lawrence Wangh of Brandeis University. ThermaGenix has an exclusive license to the ThermaStop™, ThermaGo™ and ThermaStopRT™ patents from Brandeis.
ThermaGenix is committed to empowering scientists all over the world with the highest performing PCR additives. Our innovative PCR additives improve polymerase specificity and fidelity, enhancing end point data and achieving superior amplicons for downstream applications. From genotyping to Gibson assembly, next generation sequencing sample preparation to diagnostics, ThermaGenix technology will maximize PCR performance.
We are passionate, dedicated individuals with a track record of inventing, commercializing and supporting innovative products for life science research.
click or touch name to expand profile
LAWRENCE WANGH, Ph.D.
Brandeis Professor of Biology
World expert in advanced PCR techniques
Inventor of LATE-PCR
35 years’ Life Science Product Invention and Innovation
More than 30 Patented Products and Processes
Life Science Product and Process Veteran
31 years’ Sales and Marketing experience in Life
Science Instrumentation and Consumables
5 Company Start-ups and Numerous New Product Launches
Commercial Operations Veteran
AQUILES SANCHEZ, Ph.D.
HEAD APPLICATION SCIENTIST
Scientist and inventor of LATE-PCR technology
Molecular diagnostic assay development
JOHN RICE, M.S.
Master’s in Genetics from Texas A&M University, College Station
Co-founder of Thermagenix with 20 years of molecular diagnostic experience and a co-inventor of numerous patents
Managed and conducted several projects that expanded the platform chemistry resulting in two patented (small molecule) PCR additives, which increase PCR fidelity and multiplex capabilities.